---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-044278"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:45:44.642149+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NAYA Biosciences regains Nasdaq equity compliance; faces one-year monitor

## Summary
- Received Nasdaq notice dated Oct 30, 2024 confirming compliance with Listing Rule 5550(b)(1) (Equity Rule).
- Compliance follows June 18, 2024 Panel decision; company under mandatory panel monitor for one year.
- No financial results or operational updates disclosed in this filing.

## SEC filing metadata
- accession: 0001493152-24-044278
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224044278/0001493152-24-044278-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224044278/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-044278
- JSON: https://secwatch.observer/filing/0001493152-24-044278.json
- Plain text: https://secwatch.observer/filing/0001493152-24-044278.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.